Clinical Trial Update: Chronic Kidney Disease Registry Platform Study

View source ↗

Summary

AstraZeneca's Chronic Kidney Disease Registry Platform Study is currently active but not recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Diseases | Status: ACTIVE_NOT_RECRUITING